Research found that English towns with a medieval Jewish population have higher tolerance towards 21st-century immigrants. Survey respondents in these towns showed less support for anti-immigration parties and had more positive attitudes towards immigration.
A new perspective article suggests a shift towards precision medicine, identifying 'treatable traits' in each patient to tailor management. This approach aims to improve patient outcomes by recognizing the clinical and biological complexity of airway diseases.
Researchers have linked schizophrenia symptoms to specific brain features using magnetic resonance imaging (MRI). The study identified distinctive subgroups among patients with different symptoms. Analyzing the brain's anatomy may help develop more precise treatments for individual patients.
A promising new cancer drug developed by CSIRO's Cancer Therapeutics CRC has been licensed to US pharmaceutical company Merck in a $730 million deal. The drug targets the protein PRMT5, associated with various cancers, and may also provide disease-modifying treatment options for blood disorders.
The DComm programme explores deictic communication, a fundamental aspect of human interaction, and its application in technology, education, and clinical settings. Researchers will investigate how deictic communication affects individuals with Autism Spectrum Disorder and stroke patients.